Eli Lilly & Co. (LLY) is up more than 8% so far Thursday morning after reporting second-quarter earnings that easily surpassed the Wall Street consensus. The company also raised its guidance for the full year. The drugmaker posted adjusted earnings per share of $3.92, well ahead of the $2.60 that was expected by analysts. [...]